TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
GNLX

Genelux Corporation

Healthcare · Biotechnology

2.50$ +2.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Genelux Corporation (GNLX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 26 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GNLX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
34 28 25 45 40 35 39 32 25 19 32 26
31 24 21 35 36 32 36 29 22 15 27 19
30 9.4 4.1 7.9 6.1 8.6 16 6.5 3.7 5.3 9.3 9.2
30 23 20 34 34 31 35 28 20 15 26 19
10 8.4 9.6 7.5 7.2 8.4 9.1 8.3 6.4 7.5 9.5 10
8.8 6.6 7.8 5.8 5.6 6.9 7.7 7.0 5.1 6.2 7.3 8.0
0.6 0.7 0.6 0.5 0.4 0.3 0.3 0.3 0.4 0.4 0.3 0.3
4.0 3.8 5.3 4.8 4.5 5.6 6.7 6.0 4.0 4.4 6.1 –
24 19 15 38 33 26 30 24 19 12 23 16
-215 -222 -229 -236 -242 -251 -259 -266 -274 -284 -292 -302
27 27 27 30 35 31 35 38 38 37 33 45

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?